Skip to main content
. Author manuscript; available in PMC: 2016 Nov 1.
Published in final edited form as: Circ Heart Fail. 2015 Aug 14;8(6):1068–1076. doi: 10.1161/CIRCHEARTFAILURE.114.001976

Figure 2. Kaplan-Meier analysis of major adverse cardiac events (MACE) in participants with heart failure.

Figure 2

(A) Heart failure patients (n=245) stratified according to optimal cutoff for plasma marinobufagenin (MBG) as follows: “Low” MBG (<574 pM) or “High” MBG (≥ 574 pM). (B) Subgroup analysis of heart failure patients (n=115) with serial blood draws from admission to pre-discharge at 48-72 hours stratified according to optimal cutoff for change in plasma MBG as follows: “decreasing” MBG (<5%) or “increasing” MBG (≥ 5%).